ScreenerHero
ALZCURAlzeCure Pharma AB (publ)
STO · SE · Healthcare · Biotechnology · alzecurepharma.se
6.420SEK-3.31%Mkt Cap: 80.62M $P/E: —

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involv…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap80.62M $
Enterprise Value70.05M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-4.56M $
Revenue/Share—
Last Price6.420 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-55.17
PEG—
EV/EBITDA-12.55
EV/Revenue—
P/S—
P/B67.55
EPS (TTM)-0.48
EPS (Forward)-0.12
52W Range
1.30076% of range8.060
52W High8.060 SEK
52W Low1.300 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-144.75%
ROA-80.71%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.31M $
CapEx (TTM)—
FCF Margin—
FCF Yield-2.12%
Net Debt-2.93M $
Net Debt/EBITDA0.53
Balance Sheet
Debt/Equity0.08
Current Ratio1.36
Quick Ratio1.30
Book Value/Sh0.0980 SEK
Cash/Share0.2870 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)14.30 SEK
Upside (mean)+122.7%
Target Range14.30 SEK – 14.30 SEK
# Analysts1
Ownership
Shares Out.131.28M
Float76.79M
Insiders39.58%
Institutions12.68%
Technical
SMA 505.782 (+11.0%)
SMA 2002.812 (+128.3%)
Beta-0.09
S&P 52W Chg18.16%
Avg Vol (30d)281.53K
Avg Vol (10d)280.59K
Technical Indicators
RSI (14)58.3
MACD0.3018
MACD Signal0.3639
MACD Hist.-0.0621
BB Upper7.014 SEK
BB Middle6.511 SEK
BB Lower6.008 SEK
BB Width15.44%
ATR (14)0.3898 SEK
Vol Ratio (20d)0.89x